Concepedia

Brandy M. Snider

BM

4

Publications

182

Citations

4

H-Index

2019

Active since

Affiliations

Eli Lilly (United States)(Current)

Brandy M. Snider is an author at Eli Lilly (United States) specializing in social sciences, neuropharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2019–2024

4

Publications

4

Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation

Alessia Costa, Minrong Ai, Nicolas Nunn et al. · Molecular Metabolism · 2021 · 66 citations · Full text

GIPR Agonism Inhibits PYY-Induced Nausea-Like Behavior

Ricardo J. Samms, Richard Cosgrove, Brandy M. Snider et al. · Diabetes · 2022 · 59 citations · Full text

, , +16

Long-Acting and Selective Oxytocin Peptide Analogs Show Antidiabetic and Antiobesity Effects in Male Mice

Brandy M. Snider, Andrea Geiser, Xiaopeng Yu et al. · Journal of the Endocrine Society · 2019 · 33 citations · Full text

The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron

Kyle W. Sloop, Amy L. Cox, David B. Wainscott et al. · Science Translational Medicine · 2024 · 24 citations

Rows per page

1–4 of 4